购物车里还没有商品。
特色
描述
研究领域
Cardiovascular Research, Inflammation, Inflammatory Mediators, Macrophage
图片与验证
−
Item 1 of 1
| 已测应用 | WB |
|---|---|
| 稀释范围 | WB=1:500-2000 |
| 反应性 | Human, Mouse, Rat |
| 预测反应性 | Guinea pig, Sheep |
关键属性
−| 抗体类型 | Primary Antibody |
|---|---|
| 宿主 | Rabbit |
| 克隆性 | Polyclonal |
| 同种型 | IgG |
| 免疫原 | KLH conjugated synthetic peptide derived from human CMA1 (28-42/247aa) |
| 靶点 | CMA1 |
| 分子量 | 23 kDa |
| 纯化 | Affinity purified by Protein A |
| 偶联 | Unconjugated |
储存与操作
−| 储存 | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| 形态/外观 | Liquid |
| 缓冲液/防腐剂 | 0.01M TBS (pH7.4) with 1% rAlbumin, 0.02% Proclin300 and 50% Glycerol. |
| 浓度 | 1mg/ml |
| 有效期 | 12 months from date of receipt. |
| 免责声明 | For research use only |
别名
−CYH; MCT1; chymase; MMCP-5; Mcp-5; Mcp5; Mcpt5; CMA1_HUMAN; CMA1; Alpha-chymase; Mast cell protease I; 3.4.21.39; CYM; CMA1_MOUSE; Mast cell chymase 1; Mast cell protease 5 (mMCP-5); chymase 1; chymase 1, mast cell
相似产品
−- Item 1 of 7
CMA1 Rabbit Polyclonal Antibody [orb3160373]
ELISA, ICC, IHC, WB
Human, Mouse, Rat
Rabbit
Polyclonal
Unconjugated
50 μl, 100 μl - Item 1 of 4
CMA1 Rabbit Polyclonal Antibody [orb3161120]
ELISA, ICC, WB
Human, Mouse, Rat
Rabbit
Polyclonal
Unconjugated
50 μl, 100 μl 
- Item 1 of 2
CMA1 Rabbit Polyclonal Antibody [orb584539]
IHC, WB
Bovine, Canine, Guinea pig, Mouse, Rabbit, Rat, Sheep
Human
Rabbit
Polyclonal
Unconjugated
100 μl
质量保证
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our 条款与条件和选购指南.
常用数据库链接
基因符号
CMA1
UniProt
UniProt 详情
−暂无 UniProt 数据
Zeng, Huizhi et al. Resveratrol improves prostate fibrosis during progression of urinary dysfunction in chronic prostatitis by mast cell suppression Mol Med Rep, 17, 918-924 (2018)
